isomethyleugenol has been researched along with Synovioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Khalil, EZI; Osman, NAA | 1 |
| Choy, E; Cote, GM; Duan, Z; Gao, Y; Hornicek, FJ; Mankin, HJ; Shen, JK | 1 |
| Eid, JE; Garcia, CB; Shaffer, CM | 1 |
3 other study(ies) available for isomethyleugenol and Synovioma
| Article | Year |
|---|---|
The combined use of H3K27 trimethylation and TLE1 can provide additional diagnostic value for malignant peripheral nerve sheath tumor and synovial sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Co-Repressor Proteins; Female; Histones; Humans; Immunohistochemistry; Jumonji Domain-Containing Histone Demethylases; Male; Methylation; Middle Aged; Neurofibrosarcoma; Sarcoma, Synovial; Young Adult | 2020 |
Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Gene Knockdown Techniques; Histones; Humans; Lysine; Methylation; Protein Processing, Post-Translational; Sarcoma, Synovial | 2016 |
Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2.
Topics: Animals; Cell Line; Chromatin; Epigenesis, Genetic; Histones; Humans; Methylation; Mice; Oncogene Proteins, Fusion; Polycomb-Group Proteins; Protein Binding; Protein Transport; Sarcoma, Synovial | 2012 |